Targeting Telomere Shelterin Protein TPP1 with Elbasvir: Induction of Autophagyand Suppression of Esophageal Cancer Tumorigenesis
TPP1 emerges as a compelling diagnostic indicator and a potential treatment focus in esophageal cancer, with Elbasvir offering promise as a novel therapeutic agent.
Authors
- Maoju Tang
- Xiaowu Zhong (ORCID: https://orcid.org/0000-0001-5143-5838)
- Xiaolan Guo (ORCID: https://orcid.org/0000-0001-5113-0022)
- Jiling Wen (ORCID: https://orcid.org/0000-0001-5337-694X)
- Miyuan Yang
- Lei Xu (ORCID: https://orcid.org/0000-0002-9241-7019)
- Qiang Ma (ORCID: https://orcid.org/0000-0002-2249-7180)
- Xiao Liu (ORCID: https://orcid.org/0000-0002-8073-0534)
Institutions
- North Sichuan Medical University (CN)
- Affiliated Hospital of North Sichuan Medical College (CN)
- Nanchong Central Hospital (CN)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-10-09
- DOI
- https://doi.org/10.2174/0118715206393619250911115554
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00